Texas Man Sues AstraZeneca Over Andexxa Stroke Claims
A lawsuit alleges the stroke and vision loss follow the use of a drug later recalled by the FDA for blood clot risks.
Updated on Oct. 22, 2026 in Stroke
Roger Naumann has filed a lawsuit against AstraZeneca, alleging the company's now-recalled drug Andexxa caused him to suffer a stroke and permanent vision impairment. The legal action follows an FDA decision to pull the reversal agent from the U.S. market in late 2025.
Why it matters
The case highlights the risks associated with Andexxa, which was originally approved to reverse the effects of certain blood thinners. The FDA ultimately determined that the medication's potential to trigger dangerous blood clots outweighed its clinical benefits.
FDA findings linked Andexxa to a 14.6% incidence rate of adverse blood clot effects. This figure significantly exceeded the 6.9% rate observed among patients receiving standard medical treatment.
The players
Roger Naumann
He is the plaintiff in the lawsuit filed against AstraZeneca following his medical complications.
AstraZeneca
This is a global pharmaceutical company that manufactured and marketed the reversal agent Andexxa.
Food and Drug Administration
The federal agency responsible for regulating medical products and overseeing drug recalls in the United States.
The details
AstraZeneca manufactured Andexxa as a reversal agent for blood thinners such as Eliquis and Xarelto. The lawsuit, filed in the U.S. District Court for the Southern District of Texas, seeks damages for the plaintiff's health complications.
Timeline
2018: Andexxa was first approved for use in the U.S.
December 2025: The FDA announced an Andexxa recall.
October 15, 2026: Roger Naumann filed a lawsuit against AstraZeneca.
Health Landscape
This litigation follows the formal FDA drug recall process, which serves as the primary regulatory mechanism for removing pharmaceuticals from the market when safety risks are identified. The case reflects a broader trend of legal challenges following the discovery of unexpected drug-related side effects.
Patients who were prescribed Andexxa as a reversal agent for blood thinners may need to consult with their healthcare providers regarding their medical history and past treatments. This legal action serves as a reminder to report any persistent health complications to medical professionals following the use of recalled pharmaceutical products.
The takeaway
Patients should remain vigilant about the potential side effects of prescription medications even after they have been approved for use. Monitoring personal health outcomes and discussing any concerns with a primary care physician can help identify adverse events early.
Further reading
For more information on the impact of vascular health, visit our Stroke section.
Source note: This article includes information reported by AboutLawsuits.
